CHIA SEEDS: Novel Considerations in Therapeutics

In this study we evaluated and compared hypolipidemic efficacy of chia seeds and niacin. The study was conducted at National hospital, Lahore Pakistan from August 2019 to December 2019. Ninty hyperlipidemic patients were selected from cardiology and medical wards of the hospital. They were divided in three groups, one on placebo, another on chia seeds and third one on Niacin. After one and half month, significant changes (p value ranging from <0.05 to <0.001) were observed in their FBS, LDL and HDL-cholesterol. Conclusion of the study was to recommend use of chia seeds and Niacin for prevention and treatment of diabetes mellitus type 2 and secondary hyperlipidemia with good patient compliance.